Search
for
Sort by
Research 331–360 of 1000+
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Reporting on Adverse Clinical Events
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Endocrine Influences on Hair Growth
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Teriflunomide in multiple sclerosis: an update
- Recent Trends and Future Prospects of Phytosomes: A Concise Review
- Ottawa, Ontario, Canada, February 13–16, 2013
- Phytochemistry and Pharmacological Studies of Glycyrrhiza glabra: A Medicinal Plant Review
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- SINDROMA CUSHING PADA KEHAMILAN
- Current and future pharmacotherapy for alopecia areata
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- NEW YORK DERMATOLOGICAL SOCIETY
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Evidence for the off-label use of tofacitinib in alopecia areata
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Journal of Population Therapeutics and Clinical Pharmacology
- Ritlecitinib in severe alopecia areata: a profile of its use
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid